Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
about
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disordersTranexamic acid for reducing mortality in emergency and urgent surgeryCoagulopathy and transfusion therapy in pediatric liver transplantationReducing transfusion requirements in liver transplantationEfficacy and Safety of Antifibrinolytic Agents in Reducing Perioperative Blood Loss and Transfusion Requirements in Scoliosis Surgery: A Systematic Review and Meta-AnalysisTransfusion and coagulation management in liver transplantationEfficacy and safety of using antifibrinolytic agents in spine surgery: a meta-analysisTransfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.Does Tranexamic Acid Reduce Bleeding during Femoral Fracture Operation?Efficacy and Safety of Tranexamic Acid in Prehospital Traumatic Hemorrhagic Shock: Outcomes of the Cal-PAT StudyTranexamic acid in pediatric trauma: why not?Tranexamic acid and trauma-induced coagulopathy.Reversal of novel oral anticoagulants in patients with major bleeding.Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents.Frequent use of blood-saving measures in elective orthopaedic surgery: a 2012 Dutch blood management survey.Role of preoperative intravenous iron therapy to correct anemia before major surgery: study protocol for systematic review and meta-analysis.Efficacy of tranexamic acid in reducing allogeneic blood products in adolescent idiopathic scoliosis surgery.A systematic review and meta-analysis of the effect of prophylactic tranexamic acid treatment in major benign uterine surgery.Intraoperative Use of Epsilon Amino Caproic Acid and Tranexamic Acid in Surgeries Performed Under Cardiopulmonary Bypass: a Comparative Study To Assess Their Impact On Reopening Due To Postoperative BleedingCRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trialLow risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty.Tranexamic acid concentrations associated with human seizures inhibit glycine receptors.Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.The impact of blood transfusion on perioperative outcomes following gastric cancer resection: an analysis of the American College of Surgeons National Surgical Quality Improvement Program databaseThe safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis.Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbiditiesIntraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial.Effect of Preoperative Anemia on the Outcomes of Anterior Cervical Discectomy and Fusion.Desmopressin use for minimising perioperative blood transfusion.Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children.Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.Update in anesthesia and intensive care.Tranexamic acid for the reduction of blood loss in total knee arthroplasty.Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation.Application of Tranexamic Acid in Total Knee Arthroplasty - Prospective Randomized TrialProphylactic platelet transfusions prior to surgery for people with a low platelet count.The effectiveness and safety of antifibrinolytics in patients with acute intracranial haemorrhage: statistical analysis plan for an individual patient data meta-analysis.Efficacy and safety of tranexamic acid versus ϵ-aminocaproic acid in cardiovascular surgery.Tranexamic Acid versus Placebo to Prevent Blood Transfusion during Radical Cystectomy for Bladder Cancer (TACT): Study Protocol for a Randomized Controlled Trial.
P2860
Q24186028-ABFFE5F8-110C-4D6F-85CC-7EC5734D3278Q24201503-3A79BC37-1154-4FC1-9024-3939F28F0205Q26766108-4F609EB3-4C42-4453-9355-39AFA9D43784Q26771408-75CA886C-AB58-4886-A762-E1778FA1426FQ26783527-6A0ACFEE-3E36-4419-AF27-6B990B78CA90Q26995591-74B7A56C-50DD-43A9-8920-F085DC257132Q28535382-4BD7BE27-CCFD-4024-BB3A-46009658F453Q30243882-48EB0BB2-1993-4123-8C64-9B107A6611CCQ33619959-EBB14EDC-4F20-47B1-96B0-44D4D1DE07A0Q33788878-55CF6151-5443-4057-B3D3-F93788068E3EQ33892479-67CDAF3E-E45B-4B0D-A190-2CFE5A909AA1Q33919354-EDD104CE-50D4-4212-8CE7-A9C0B4A44503Q34326655-8D5A6545-7639-4BEA-BE49-016A03513559Q34667503-98B2BA12-7D20-487E-993C-9EE014F48E5FQ34894968-4F492E5A-FBEB-4D59-8B1E-192766B35FCCQ35206582-D4249012-D1EA-44F6-9B4C-BF66AB26A61BQ36000125-330843C0-9AB8-4C64-A818-B206EF866EDBQ36252909-AE6CFDEF-401E-415A-978D-6B4BADA53A11Q36294316-A6089F16-E34B-454F-9377-EF3AABB0FAF7Q36347953-18E0DFAC-3759-4287-8ECB-AB7F8C26AAF0Q36484729-A61DE378-CCE4-4FD8-BD29-A1C1EB808BE5Q36498021-55437B77-66DB-4768-8141-44531983B26BQ36515685-92904E5C-3917-4C47-8330-20E61B3ECA89Q37253804-3D4B9E7D-769E-42CE-B2BE-A3DF4E9EB88BQ37297382-43B6C03A-29E9-46E1-8C91-B61645829958Q37339494-42670276-C193-4BBD-858B-6285A5DC708BQ37468834-D52AE683-D636-4975-A87A-AF693F7E44B6Q38482466-CAE1B367-15AC-483D-AA3A-25F25183FAE9Q38622771-840D41C0-B7A5-4056-8002-01A3E925EC3DQ38687047-D7AFB700-F53B-407A-AFF6-2F56ED73F298Q38958444-2278499C-412B-4686-87D4-CE872FBA11BDQ39790494-F1AF77DA-8EDC-4B77-B939-94C0734CA199Q39831649-A73278FA-40BC-4479-8659-22899CB33653Q40858444-7568310D-4B99-47D9-BCDB-FC00E9545E24Q41938260-8CA7A6EB-2306-4CB5-8093-3418BF92B19FQ42363413-A092039B-9EB7-4FA7-A403-EC2D6039E412Q49899043-27937641-A2FA-4214-89B6-680DD75DC2B0Q50054586-27008649-3EE6-4A8F-9DF5-AC3AC4526980Q50460458-0C3D3840-46C5-4061-816C-69BB41C7BB54Q52714988-B9719C3B-9DE4-4C7F-BEC7-AF52D4631A76
P2860
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en-gb
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@nl
type
label
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en-gb
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@nl
prefLabel
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en-gb
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@nl
P2093
P2860
P3181
P1476
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
@en
P2093
Annette J Moxey
Barrie J Stokes
David A Henry
Dean A Fergusson
Dianne O'Connell
Paul A Carless
P2860
P304
P3181
P356
10.1002/14651858.CD001886.PUB4
P407
P577
2011-01-01T00:00:00Z